Islet Holdings IncOver The Counter Market:ISHI
- LAST PRICE0.0002
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0002
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Islet Holdings Inc | 41.2K | 0.0x | --- |
Acacia Diversified Holdings Inc | 50.0 | 0.0x | --- |
Pure Harvest Corporate Group Inc | 193.5K | 0.0x | --- |
Alternate Health Corp | 90.0 | 0.0x | --- |
PixarBio Corp | 80.0 | 0.0x | --- |
Black Bird Biotech Inc | 98.4K | -0.1x | --- |
Company Information
Islet Holdings Inc. is a biotechnology company, which is focused on cosmeceuticals. The Company is engaged in the research, development and commercialization of patented technologies in the field of transplantation in the therapy of people with conditions of insulin-dependent diabetes. The Company is developing intellectual property relating to hemp farming and extraction of cannabidiol (CBD) from hemp. Its technology constitutes methods for isolating, culturing, cryopreservation and immune-protection (microencapsulation) of islet cells. The Company's product candidates are intended for the treatment of insulin-dependent diabetes and are intended to be administered into the patient's abdominal cavity, where the transplanted islet cells will produce insulin in response to increase in blood glucose. The primary function of microencapsulation is to protect the islets from the host's immune system. The microcapsule coating is composed of layers of biocompatible materials.
Contact Information
- Headquarters
- 3060 W 3650 S Apt 92WEST VALLEY CITY, UT, United States 84119-4340
- Phone
- 385-222-6281
- Fax
- ---
Executives
- Chairman of the Board
- James Chapin
- President
- Marti Wolf
- Chief Financial Officer, Director
- Stan Wylie
- Director
- Dean Hastas
- Director
- David Lewis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.2K |
|---|---|
Revenue (TTM) | $4.1M |
Shares Outstanding | 206.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-98.16 |
Book Value | $17.85 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -109.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
